Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Clinical Research of Chimeric Antigen Receptor(CAR) T Cells Targeting CEA Positive Cancer

NCT02349724 is registered in ClinicalTrials.gov with Southwest Hospital, China as lead sponsor.

NCT NCT02349724
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02349724 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Clinical Research of Chimeric Antigen Receptor(CAR) T Cells Targeting CEA Positive Cancer
Lead sponsor
Southwest Hospital, China
Phase
Phase 1
Overall status
Unknown status
Start date
December 31, 2014
Completion date
December 31, 2019
Enrollment
75 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, colorectal cancer, gastric cancer, lung cancer, pancreatic cancer